In:
Neurodegenerative Disease Management, Future Medicine Ltd, Vol. 2, No. 2 ( 2012-04), p. 159-163
Abstract:
Georg Bernhard Landwehrmeyer is currently Professor of Neurology ‘Clinical Neurobiology’ at the University Hospital of Ulm (Germany) where he is also Chair of the Executive Committee of the European Huntington’s Disease Network. In 2011, he was predominately in New York, USA on sabbatical and is now currently a medical advisor to the CHDI Foundation. Landwehrmeyer received his Masters and PhD degrees at the Albert-Ludwigs University (Freiburg, Germany). He has also studied at the Royal Victoria Hospital, Queen’s University (Belfast, UK), Kantonsspital (Basel, Switzerland) and MGH and Harvard Medical School, Boston. From 1995 to 1999, he was a staff member at the Albert-Ludwigs University in Freiburg Medical in Residency School (Departments of Neurology and Psychiatry). In 1999, he received his Board Certification in Neurology and 1 year later, the Venia Legendi and full Professorship (‘C3’) in Neurology at the University of Ulm. He has shown his expertise, especially in the field of Huntington’s disease, in numerous clinical trials and researches both nationally and internationally.
Type of Medium:
Online Resource
ISSN:
1758-2024
,
1758-2032
Language:
English
Publisher:
Future Medicine Ltd
Publication Date:
2012
Permalink
